Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Apostolos Kontzias

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Seminars in Arthritis and Rheumatism|April 20, 2012
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's diseaseApostolos Kontzias, Petros Efthimiou
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 4, 2021
Expansion of Phenotypic and Genotypic Spectrum in Yao Syndrome: A Case SeriesQingping Yao, Apostolos Kontzias
Drugs|February 9, 2008
Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advancesApostolos Kontzias, Petros Efthimiou
Current Cardiology Reports|September 10, 2020
Pericarditis in Systemic Rheumatologic DiseasesApostolos Kontzias, Amir Barkhodari, QingPing Yao
Therapeutic Advances in Musculoskeletal Disease|September 9, 2022
New insights on multigenic autoinflammatory diseasesPetros Efthimiou, Olga Petryna, Priscila Nakasato, et al.
Mediterranean Journal of Rheumatology|May 17, 2024
Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease ContinuumApostolos Kontzias, Olga Petryna, Priscila Nakasato, et al.
F1000 Medicine Reports|March 10, 2012
Kinase inhibitors in the treatment of immune-mediated diseaseApostolos Kontzias, Arian Laurence, Massimo Gadina, et al.
Nature Clinical Practice. Rheumatology|June 1, 2007
Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?Petros Efthimiou, Apostolos Kontzias, Carla M Ward, et al.
Current Opinion in Pharmacology|July 24, 2012
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseApostolos Kontzias, Alexander Kotlyar, Arian Laurence, et al.
Annals of the Rheumatic Diseases|March 28, 2013
Janus kinase inhibitors in autoimmune diseasesJohn J O'Shea, Apostolos Kontzias, Kunihiro Yamaoka, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Seminars in Arthritis and Rheumatism|April 20, 2012
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's diseaseApostolos Kontzias, Petros Efthimiou
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 4, 2021
Expansion of Phenotypic and Genotypic Spectrum in Yao Syndrome: A Case SeriesQingping Yao, Apostolos Kontzias
Drugs|February 9, 2008
Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advancesApostolos Kontzias, Petros Efthimiou
Current Cardiology Reports|September 10, 2020
Pericarditis in Systemic Rheumatologic DiseasesApostolos Kontzias, Amir Barkhodari, QingPing Yao
Therapeutic Advances in Musculoskeletal Disease|September 9, 2022
New insights on multigenic autoinflammatory diseasesPetros Efthimiou, Olga Petryna, Priscila Nakasato, et al.
Mediterranean Journal of Rheumatology|May 17, 2024
Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease ContinuumApostolos Kontzias, Olga Petryna, Priscila Nakasato, et al.
F1000 Medicine Reports|March 10, 2012
Kinase inhibitors in the treatment of immune-mediated diseaseApostolos Kontzias, Arian Laurence, Massimo Gadina, et al.
Nature Clinical Practice. Rheumatology|June 1, 2007
Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?Petros Efthimiou, Apostolos Kontzias, Carla M Ward, et al.
Current Opinion in Pharmacology|July 24, 2012
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseApostolos Kontzias, Alexander Kotlyar, Arian Laurence, et al.
Annals of the Rheumatic Diseases|March 28, 2013
Janus kinase inhibitors in autoimmune diseasesJohn J O'Shea, Apostolos Kontzias, Kunihiro Yamaoka, et al.
Pageof 3